Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Claudio Fantini

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Chemico-Biological Interactions|June 1, 2024
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studiesAmalia Di Petrillo, Chiara Siguri, Giovanna L Delogu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 26, 2019
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaignMarco Vincenzo Lenti, Alessandro Armuzzi, Fabiana Castiglione, et al.
Journal of Crohn'S & Colitis|April 29, 2017
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense OligonucleotideIrene Marafini, Ivan Monteleone, Vincenzo Dinallo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2023
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensusSandro Ardizzone, Alessandro Armuzzi, Flavio Caprioli, et al.
Inflammatory Bowel Diseases|May 23, 2020
Multidimensional Impact of Mediterranean Diet on IBD PatientsFabio Chicco, Salvatore Magrì, Arianna Cingolani, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European ConsensusMassimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Infection and Immunity|January 24, 2007
Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferationIlaria Peluso, Daniele Fina, Roberta Caruso, et al.
Frontiers in Immunology|August 28, 2018
Reciprocal Regulation Between Smad7 and Sirt1 in the GutSilvia Sedda, Eleonora Franzè, Gerolamo Bevivino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 15, 2023
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Claudio Papi, Ambrogio Orlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2022
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Chemico-Biological Interactions|June 1, 2024
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studiesAmalia Di Petrillo, Chiara Siguri, Giovanna L Delogu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 26, 2019
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaignMarco Vincenzo Lenti, Alessandro Armuzzi, Fabiana Castiglione, et al.
Journal of Crohn'S & Colitis|April 29, 2017
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense OligonucleotideIrene Marafini, Ivan Monteleone, Vincenzo Dinallo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2023
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensusSandro Ardizzone, Alessandro Armuzzi, Flavio Caprioli, et al.
Inflammatory Bowel Diseases|May 23, 2020
Multidimensional Impact of Mediterranean Diet on IBD PatientsFabio Chicco, Salvatore Magrì, Arianna Cingolani, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European ConsensusMassimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Infection and Immunity|January 24, 2007
Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferationIlaria Peluso, Daniele Fina, Roberta Caruso, et al.
Frontiers in Immunology|August 28, 2018
Reciprocal Regulation Between Smad7 and Sirt1 in the GutSilvia Sedda, Eleonora Franzè, Gerolamo Bevivino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 15, 2023
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Claudio Papi, Ambrogio Orlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2022
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi, et al.
Pageof 8